Can topical application of tranexamic acid reduce blood loss in thoracic surgery? A prospective randomised double blind investigation.

The systemic or topical use of antifibrinolytic agents is effective in reducing postoperative bleeding and blood product transfusion in cardiac surgery. We sought to study the effect of the topical application of tranexamic acid into the pleural space to reduce postoperative bleeding after lung surgery.
This was a prospective randomised double blind placebo controlled investigation. From May-2010 to February-2012, 89-patients, scheduled for pulmonary resection, were randomly allocated to one of the two study groups. Group-A received 5 g of tranexamic-acid in 100 ml of saline solution. Group-B received 100 ml of saline solution as placebo.
The blood loss in the first 12-h was significantly less in group-A. The same trend was observed in the first 24-h but without reaching a true statistical significance. The mean volume of blood transfusion was statistically lower in group-A. The analysis between post-operative haemoglobin concentration, haematocrit, platelet-count, international-normalised-ratio, fibrinogen and partial-thromboplastin-time of both groups was not statistically significant.
In our experience, the topical use of tranexamic-acid after lung surgery reduces postoperative bleeding and blood transfusion volume. The topical administration of tranexamic-acid is safe without increasing the risk of post-operative complications related to pharmacological side-effects.
AuthorsAndrea Dell'Amore, Guido Caroli, Asadi Nizar, Nicola Cassanelli, Giulia Luciano, Domenico Greco, Giampiero Dolci, Alessandro Bini, Franco Stella
JournalHeart, lung & circulation (Heart Lung Circ) Vol. 21 Issue 11 Pg. 706-10 (Nov 2012) ISSN: 1444-2892 [Electronic] Australia
PMID22842057 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2012 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.
Chemical References
  • Antifibrinolytic Agents
  • Tranexamic Acid
  • Administration, Topical
  • Aged
  • Antifibrinolytic Agents (administration & dosage, adverse effects)
  • Blood Loss, Surgical (prevention & control)
  • Blood Transfusion
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage (blood, prevention & control)
  • Prospective Studies
  • Thoracic Surgery
  • Tranexamic Acid (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: